Forte Biosciences, Inc. · NASDAQ:FBRX
Orbimed Advisors LLC reported a 6.20% stake in Forte Biosciences, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Orbimed Advisors LLC reported a 6.20% stake in Forte Biosciences, Inc., 1,264,980 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 6.20%
- Shares
- 1,264,980
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| ORBIMED ADVISORS LLC | 6.20% | 1,264,980 |
| OrbiMed Capital GP IX LLC | 5.10% | 1,041,742 |
| ORBIMED CAPITAL LLC | 1.50% | 312,725 |
Source
Related
- Forte Biosciences, Inc.
- Orbimed Advisors LLC
- Forte Biosciences, Inc. shareholders
- Schedule 13G/A · Orbimed Advisors LLC · May 15, 2026
- Schedule 13G · Orbimed Advisors LLC · Feb 14, 2025
- Schedule 13G/A · Federated Hermes, Inc. · Sep 8, 2026
- Form 4 · Kornfeld Steven · Aug 27, 2026
- Form 4 · Gryska David W · Aug 27, 2026
- Form 4 · Riley Antony A · Aug 27, 2026
- Form 4 · Wagner Paul A. · Aug 27, 2026